Dioralyte Rehydration Therapy

Dioralyte is a leading brand of oral rehydration therapy (ORT) used to replace essential water and body salts lost during episodes of diarrhea or vomiting. Originally formulated to combat dehydration, the brand has become a staple in household medicine cabinets and clinical settings worldwide due to its effective electrolyte balance and ease of use.

Manufacturing for Dioralyte typically takes place in Europe, specifically within specialized pharmaceutical facilities in France, though the supply chain may involve different regional hubs depending on the specific market packaging. The brand's history is deeply rooted in European pharmaceutical innovation, focusing on pediatric and adult gastrointestinal health.

While Dioralyte was part of the Sanofi portfolio for many years, it is currently owned by Stada Arzneimittel AG. Stada, a German-based pharmaceutical giant, acquired Dioralyte alongside several other consumer healthcare brands to strengthen its position in the European market. This acquisition ensures that Dioralyte continues to be distributed globally through various local subsidiaries and licensed distributors, maintaining its status as a trusted brand for managing dehydration.